Bleeding risk during treatment of acute thrombotic events with subcutaneous LMWH compared to intravenous unfractionated heparin; a systematic review.

Bleeding risk during treatment of acute thrombotic events with subcutaneous LMWH compared to intravenous unfractionated heparin; a systematic review.

BACKGROUND: Low Molecular Weight Heparins (LMWH) are at least as effective antithrombotic drugs as Unfractionated Heparin (UFH). However, it is still unclear whether the safety profiles of LMWH and UFH differ. We performed a systematic review to compare the bleeding risk of fixed dose subcutaneous L...

Full description

Bibliographic Details
Main Authors: Giorgio Costantino, Elisa Ceriani, Anna Maria Rusconi, Gian Marco Podda, Nicola Montano, Piergiorgio Duca, Marco Cattaneo, Giovanni Casazza
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3439371?pdf=render

Internet

http://europepmc.org/articles/PMC3439371?pdf=render

Similar Items